Shares of FibroGen dropped 6.31% to $20.63 at 15:23 EST on Tuesday, after two consecutive sessions in a row of losses. NASDAQ Composite is falling 2.31% to $13,574.72, after two successive sessions in a row of losses. This seems, as yet, an all-around negative trend trading session today.
FibroGen’s last close was $22.02, 177.31% under its 52-week high of $57.21.
The company’s growth estimates for the current quarter and the next is 2.2% and 51.6%, respectively.
Year-on-year quarterly revenue growth grew by 715.1%, now sitting on 176.32M for the twelve trailing months.
FibroGen’s Stock Yearly Top and Bottom Value
FibroGen’s stock is valued at $20.63 at 15:23 EST, way below its 52-week high of $57.21 and higher than its 52-week low of $20.49.
FibroGen’s Moving Average
FibroGen’s value is way below its 50-day moving average of $39.14 and way below its 200-day moving average of $42.31.
More news about FibroGen.